SpeechVive Inc.

SpeechVive is a wearable medical device company specializing in speech enhancement technology for patients with Parkinson's Disease. The SpeechVive device is a Class I, FDA-registered medical device that automatically triggers louder, slower, and clearer speech during communication, addressing hypokinetic dysarthria—a common speech disorder in Parkinson's patients. The device provides immediate improvement in speech volume and clarity without requiring intensive traditional speech therapy programs. Designed for both patient self-use and clinician-supported care, SpeechVive is Medicare-approved, accepted by the Veterans Administration, and covered by commercial insurance plans. The company focuses on empowering patients, caregivers, and speech-language pathologists with an evidence-based alternative to behavioral therapy, enabling patients to maintain communication independence and quality of life.